HGPI
December 9, 2022 Online Seminar “Thinking about Infectious Diseases in Small Animal Clinical Practice and Their Future – Current Status and Countermeasures for Antimicrobial Resistance – Companion Animals and Emerging Infectious Diseases -”
Health and Global Policy Institute (HGPI) (Secretariat: Chiyoda-ku, Tokyo, Representative Director: Kiyoshi Kurokawa) will hold an online seminar on drug resistance in pets on Friday, December 9, 2022. To do. Along with COVID-19, antimicrobial resistance (AMR) is an issue that requires immediate action. Just as COVID-19 is an infectious disease common to humans and animals, drug resistance is also closely related to animals such as dogs, cats, birds, and hamsters that live with you, and to the global environment in which we live. .
It is estimated that 10 million people worldwide will die by 2050 if measures against drug resistance are not taken forward. Considering the lives and livelihoods of animals and the impact on the global environment, the damage will be enormous.
For humans and animals to live safely and happily, each of us needs to learn about antimicrobial resistance and take action.
[Image
 19:00-20:15 (with Q&A) ■ Speakers:
Mr. Yoshiteru Murata (Director, Murata Animal Hospital / Visiting Professor, Tokyo University of Agriculture and Technology Future Epidemiology Research Center / Chairman, Veterinary Clinical Infectious Disease Research Group)
Graduated from Kitasato University School of Veterinary Medicine in 1980, received master's degree in veterinary science from Kitasato University Graduate School in 1982, worked at Sawaki Dog and Cat Hospital, and since 1984 has been Director of Murata Animal Hospital. In 2009, received a doctorate in medicine (medical mycology) from Chiba University Graduate School of Medicine and Pharmaceutical Sciences. He has written many papers and books on infectious diseases related to pets in Japan and overseas. In 2013, he served as chairman of the Veterinary Clinical Infectious Disease Research Association (VICA), a group of experts on clinical infectious diseases in the field of small animals. ” is awarded. Worked on surveys of
drug-resistant bacteria isolated from pets, created guidelines for veterinarians, and contributed to academic societies, collaborative symposiums, case review meetings, and various specialized journals on the importance of appropriate and careful use of antimicrobials. We have been disseminating and enlightening through such as. We are promoting AMR countermeasures while considering the one health of humans, animals, and the environment at the clinical site of pets. ■ Format: Online (Zoom webinar)
■ Participation fee: Free
■ Capacity: 500 people
■ How to register: Please apply using the Zoom webinar form below. <a href=)
・[About Health and Global Policy Institute]
The Health and Global Policy Institute (HGPI) is a non-partisan, private-sector organization whose mission is to “provide policy options to society by bringing together a wide range of stakeholders as an independent think tank to realize citizen-centered healthcare policies.” • A non-profit health policy think tank. All stakeholders, including Japan’s leading experts, citizen/patient representatives, medical providers, policy makers, and business people, participate in activities in areas such as “citizen/patient-centered medical care,” “important issues in healthcare policy,” and “global health.” , conducts surveys and makes policy proposals, and supports the realization of policies. Please refer to (http://www.hgpi.org/) for more information about this organization.
Details about this release:
https://prtimes.jp/main/html/rd/p/000000018.000007152.html